BCG-RD1

N/A

Report date: 2025/01/26 18:26:08

Base Information

Drug NameBCG-RD1
Drug Alias Namerecombinant BCG strains expressing the Mycobacterium tuberculosis ESX-1 secretion (James Cook University of North Queensland)BCG-RD1
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJames Cook University, Queensland, Australia
China Registration ClassN/A

Develop Information

Active CompaniesJames Cook University, Queensland, Australia
Inactive CompaniesN/A
Active IndicationsTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A